Peptides offer prospects for Alzheimer's treatment
30 May, 2016Biotech company Alzhyme has licensed a range of peptides, developed at the University of Tasmania, which have the potential to treat Alzheimer's disease.
AusCann and Murdoch Uni sign medical cannabis research alliance
25 May, 2016AusCann has announced a five-year research alliance with Murdoch University, intended to lead to the development of projects in the field of medicinal cannabis.
Biotron boasts anti-Zika drug compounds
23 May, 2016Shares in Biotron jumped 25% as the company announced that two compounds from its library have shown positive activity against Zika virus.
Australia's edge in early-phase clinical trials
20 May, 2016Cost, regulatory speed and flexibility and quality are the key drivers for biopharma companies selecting Australia for early-phase trials, according to a new report.
Diabetes monitoring through human sweat
19 May, 2016Korean scientists have created a wearable patch that allows accurate diabetes monitoring and feedback therapy by using human sweat.
Helping wrist fractures heal faster
17 May, 2016IPAS and Austofix have collaborated on the development the VRP 2.0 (Volar Radius Plate) — an innovative device that will help wrist fractures heal faster and can be fitted more easily by surgeons.
Enrolment completed in stem cell trial for osteoarthritis
16 May, 2016Regeneus has completed the enrolment of all 20 patients in its STEP trial — the first clinical trial of its allogeneic off-the-shelf MSC product for the treatment of knee osteoarthritis.
AusCann partners with world's largest legal cannabis company
09 May, 2016AusCann has announced a partnership agreement with Canada's Canopy Growth Corporation, the largest legal cannabis producer in the world.
Cell harvesting device treats burns and vitiligo
09 May, 2016Avita Medical's ReCell autologous cell harvesting device effectively reduces the occurrence of long-term scarring and itching symptoms associated with paediatric burn treatment and can also be used as a treatment for the skin condition vitiligo.
Patents and production announced for MSC product
06 May, 2016Cynata Therapeutics has had a busy week, announcing a successful patent for its Cymerus mesenchymal stem cell (MSC) technology, a patent application describing certain novel aspects of the technology and the manufacture of its clinical trial product.
Orthocell receives ethics approval for collagen scaffold study
04 May, 2016Orthocell has been granted ethical approval by St Vincent's Hospital Melbourne for a clinical study using its Celgro SMRT Grant collagen scaffold.
Clinical trials facility opens in Adelaide
02 May, 2016Pharmaceutical company IDT Australia has officially opened CMAX Adelaide, claimed to be Australia's largest and most contemporary early-phase clinical trial facility.
AusMedtech is coming to Adelaide
28 April, 2016Australian medical technology conference AusMedtech is coming to the Adelaide Convention and Exhibition Centre from 10–11 May.
Wet AMD trial meets primary safety objective
26 April, 2016Opthea has met the primary objective of safety in the dose escalation of its ongoing first-in-human clinical trial of OPT-302, a therapy for wet age-related macular degeneration (wet AMD) — the leading cause of blindness in the Western world.
CSL marks centenary with $25 million fellowship program
26 April, 2016Biotechnology company CSL observed a significant milestone on 25 April — 100 years of operation. As part of its birthday celebrations, the company is creating a flagship $25 million fellowship program for early-stage and translational research in Australia.
